You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藥明康德(02359.HK)擬發行5億美元於2025年到期的零息有擔保可轉換債券

格隆匯10月8日丨藥明康德(02359.HK)發佈公吿,2024年10月7日,發行人(藥明康德(香港)有限公司,為公司的全資附屬公司)、公司及牽頭經辦人(即Citigroup Global Markets Limited)簽署認購協議,根據該協議並在達成所載若干條件的前提下,發行人已同意發行,而牽頭經辦人同意認購和支付(或促使認購人認購和支付)本金為5億美元的債券(5億美元於2025年到期的零息有擔保可轉換債券,可由持有人選擇按初步轉換價每股H股80.02港元轉換為公司每股面值人民幣1.00元的繳足普通H股)。

債券可於條款及條件所載情況下按初步轉換價每股H股80.02港元(可調整)轉換為H股。初步轉換價為每股H股80.02港元,較於2024年10月7日(即簽署認購協議的交易日)在香港聯交所所報最後收市價每股H股69.00港元溢價約15.97%。

假設按初步轉換價每股H股80.02港元悉數轉換債券,則債券將轉換為約4852.22萬股H股,相當於公司於本公吿日期已發行總H股股本約12.54%及已發行總股本約1.67%,以及公司悉數轉換債券後的經擴大已發行總H股股本約11.14%及經擴大已發行總股本約1.64%。待債券發行完成後,認購債券所得款項淨額將約為4.944億美元。公司擬使用認購所得款項作為(其中包括)全球業務發展、債務再融資及一般公司用途。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account